Immune Checkpoint Inhibitor–Mediated Aseptic Meningitis and Hypophysitis
Immune checkpoint inhibitors have revolutionized cancer treatment, yet their use is associated with unique and sometimes unpredictable immune-related adverse events. We present a case of a 67-year-old female with renal cell cancer treated with ipilimumab and nivolumab who developed aseptic meningiti...
Saved in:
| Main Authors: | Pavel Bleik, Panisara Fangsaard, Nataliya Yuklyaeva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/crom/3517328 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune Checkpoint Inhibitor-Related Hypophysitis: A Call for Vigilance
by: Ju Hee Lee
Published: (2025-06-01) -
Analysis of the clinical characteristics of immune checkpoint inhibitor-related hypophysitis
by: Zhixiao WANG, et al.
Published: (2025-08-01) -
Hypophysitis induced by immune checkpoint inhibitors in a Scottish melanoma population
by: Khor Zhong Wei, et al.
Published: (2019-03-01) -
Pituitary enlargement and hypopituitarism in patient with lung cancer treated with immune checkpoint inhibitors: Metastasis or hypophysitis? Role of imaging
by: Pier Paolo Arcuri, MD, et al.
Published: (2025-04-01) -
High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor associated hypophysitis (CORTICI): an open, randomised controlled trial
by: Verena Theiler-Schwetz, et al.
Published: (2025-12-01)